Evidence map›Paper›PMID 33275178›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2021

EANM/SNMMI practice guideline for [

Judit A Adam, Annika Loft, Cyrus Chargari, Roberto C Delgado Bolton, Elisabeth Kidd, Heiko Schöder, Patrick Veit-Haibach, Wouter V Vogel

Open access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Meta-analysis of the diagnostic value ofFrontiers in oncology · 2022
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Tumor and metastatic lymph nodes metabolic activity onAbdominal radiology (New York) · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Implications of the Harmonization of [Tomography (Ann Arbor, Mich.) · 2022
    Article
  19. European journal of nuclear medicine and molecular imaging · 2021
    Article
  20. Give to Fryback what is Fryback's, and to new PET technologies what is new PET technologies'.European journal of nuclear medicine and molecular imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

Judit A AdamDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands. j.a.adam@amsterdamumc.nl.ORCID http://orcid.org/0000-0001-8899-8087
Annika LoftDepartment of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Cyrus ChargariBrachytherapy Unit, Gustave Roussy, Villejuif, France.
Roberto C Delgado BoltonDepartment of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro University Hospital and Centre for Biomedical Research of la Rioja (CIBIR), Logroño, La Rioja, Spain.
Elisabeth KiddDepartment of Radiation Oncology, Stanford Cancer Center, Stanford, CA, USA.
Heiko SchöderDepartment of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Patrick Veit-HaibachJoint Department of Medical Imaging, University of Toronto, Toronto, Canada.
Wouter V VogelDepartment of Nuclear Medicine and Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Amsterdam Neuroscience · NLCenter for Biomedical Research of La Rioja · ESCopenhagen University Hospital · DKInstitut Gustave Roussy · FRMemorial Sloan Kettering Cancer Center · USThe Netherlands Cancer Institute · NLUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this EANM / SNMMI Practice Guideline with ESTRO endorsement is to provide general information and specific considerations about [

methodsGuidelines from related fields, relevant literature and leading experts have been consulted during the development of this guideline. As this field is rapidly evolving, this guideline cannot be seen as definitive, nor is it a summary of all existing protocols. Local variations should be taken into consideration when applying this guideline.

conclusionThe background, common clinical indications, qualifications and responsibilities of personnel, procedure / specifications of the examination, documentation / reporting and equipment specifications, quality control and radiation safety in imaging is discussed with an emphasis on the multidisciplinary approach.

Indexed as

Fluorodeoxyglucose F18Uterine Cervical NeoplasmsFemaleHumansNeoplasm StagingPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDGCervical cancerGuidelinePET/CTPositron emission tomographyRadiation oncologyTreatment planning

Identifiers

PMID33275178
PMCPMC8041686
OpenAlexW3109479619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.